We tend to equate insulin delivery with needles: we have to! Even the best infusion sets available require inserting the cannula with the help of a needle.
But a type of insulin currently in review by the US FDA called Afrezza, if approved, will allow for insulin delivery without needles, in inhalable form.
You may remember a few years ago a failed attempt at insulin in powder form, called Exubera. The people at Mannkind (a company by Al Mann, the man who founded Minimed before it became a part of Medtronic) introduce the product as follows:
AFREZZA® (pronounced uh-FREZZ-uh) is a first-in-class, ultra rapid-acting mealtime insulin therapy being developed to improve glycemic control in adults with Type 1 and Type 2 diabetes mellitus. It is a drug-device combination product, consisting of AFREZZA Inhalation Powder single use dose cartridges, and the small, discreet and easy-to-use AFREZZA inhaler. - See more at: http://www.mannkindcorp.com/product-pipeline-diabetes-afrezza.htm#sthash.7HMJ5FQW.dpuf
I applied along with other diabetes patient advocates to speak at the FDA Advisory Committee meeting for Afrezza on April 1, and today we received confirmation about our 3 minutes to speak in front of the committee.
I want to take my opportunity to speak to bring the voice of TuDiabetes members to the committee members. Please share here HOW would a needled-free delivery system for insulin make a difference for you, whether you are currently on insulin or not... perhaps, even more so, if you are NOT on insulin but are considering it or talking with your physician about it.